Myocyte enhancer factor-2 transcription factors in neuronal differentiation and survival

Molecular Neurobiology

Volumn 29, Issue 2, 2004, Pages 155-165

  Heidenreich, Kim A ^a   Linseman, Daniel A ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Brain; Calcium signaling; Development; MADS box; Muscle; Neuron; Protein kinases

Indexed keywords

CALCIUM; MYOCYTE ENHANCER FACTOR 2; PROTEIN KINASE; TRANSCRIPTION FACTOR; DNA BINDING PROTEIN; MYOCYTE SPECIFIC ENHANCER BINDING FACTOR 2; MYOCYTE-SPECIFIC ENHANCER-BINDING FACTOR 2; MYOGENIC FACTOR;

CALCIUM SIGNALING; CELL PROLIFERATION; CELL SURVIVAL; DNA SEQUENCE; ENZYME ACTIVATION; HUMAN; IMMUNOCOMPETENT CELL; IN VITRO STUDY; NERVE CELL DIFFERENTIATION; NERVOUS TISSUE; NONHUMAN; PHOSPHORYLATION; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; GENETICS; METABOLISM; MUSCLE CELL; NERVE CELL; PHYSIOLOGY;

ANIMALS; CELL DIFFERENTIATION; CELL SURVIVAL; DNA-BINDING PROTEINS; HUMANS; MUSCLE CELLS; MYOGENIC REGULATORY FACTORS; NEURONS; TRANSCRIPTION FACTORS;

EID: 3142705929     PISSN: 08937648     EISSN: None     Source Type: Journal    
DOI: 10.1385/MN:29:2:155     Document Type: Review

References (64)

1. Yu Y.T., Breitbart R.E., Smoot L.B., Lee Y., Mahdavi V., Nadal-Ginard B. (1992) Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors. Genes Dev. 6, 1783-1798.
2. Naya F.S., Olson E. (1999) MEF2: a transcriptional target for signaling pathways controlling skeletal muscle growth and differentiation. Curr. Opin. Cell Biol. 11, 683-688.
3. Shore P., Sharrocks A.D. (1995) The MADS-box family of transcription factors. Eur. J. Biochem. 229, 1-13.
4. Breitbart R.E., Liang C.S., Smoot L.B., Laheru D.A., Mahdavi V., Nadal-Ginard B. (1993) A fourth human MEF2 transcription factor, hMEF2D, is an early marker of the myogenic lineage. Development 118, 1095-1106.
5. Leifer D., Krainc D., Yu Y.T., et al. (1993) MEF2C, a MADS/MEF2-family transcription factor expressed in a laminar distribution in cerebral cortex. Proc. Natl. Acad. Sci. USA 90, 1546-1550.
6. McDermott J.C., Cardoso M.C., Yu Y.T., et al. (1993) hMEF2C gene encodes skeletal muscle-and brain-specific transcription factors. Mol. Cell. Biol. 13, 2564-2577.
7. Martin J.F., Miano J.M., Hustad C.M., Copeland N.G., Jenkins N.A., Olson E.N. (1994) A Mef2 gene that generates a muscle-specific isoform via alternative mRNA splicing. Mol. Cell. Biol. 14, 1647-1656.
8. Moore S., Vrebalov J., Payton P., Giovannoni J. (2002) Use of genomics tools to isolate key ripening genes and analyse fruit maturation in tomato. J. Exp. Bot. 53, 2023-2030.
9. Ng M., Yanofsky M.F. (2001) Function and evolution of the plant MADS-box gene family. Nat. Rev. Genet. 2, 186-195.
10. Yun K., Wold B. (1996) Skeletal muscle determination and differentiation: story of a core regulatory network and its context. Curr. Opin. Cell Biol. 8, 877-889.
11. Black B.L., Olson E.N. (1998) Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu. Rev. Cell. Dev. Biol. 14, 167-196.
12. McKinsey T.A., Zhang C.L., Olson E.N. (2002) MEF2: a calcium-dependent regulator of cell division, differentiation and death. Trends Biochem. Sci. 27, 40-47.
13. Molkentin J.D., Firulli A.B., Black B.L., et al. (1996) MEF2B is a potent transactivator expressed in early myogenic lineages. Mol. Cell. Biol. 16, 3814-3824.
14. Molkentin J.D., Olson E.N. (1996) Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors. Proc. Natl. Acad. Sci. USA 93, 9366-9373.
15. Ornatsky O.I., McDermott J.C. (1996) MEF2 protein expression, DNA binding specificity and complex composition, and transcriptional activity in muscle and non-muscle cells. J. Biol. Chem. 271, 24927-24933.
16. Puri P.L., Sartorelli V. (2000) Regulation of muscle regulatory factors by DNA-binding, interacting proteins, and post-transcriptional modifications. J. Cell. Physiol. 185, 155-173.
17. Puri P.L., Wu Z., Zhang P., et al. (2000) Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells. Genes Dev. 14, 574-584.
18. Lin Q., Schwarz J., Bucana C., Olson E.N. (1997) Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 276, 1404-1407.
19. Bour B.A., O'Brien M.A., Lockwood W.L., et al. (1995) Drosophila MEF2, a transcription factor that is essential for myogenesis. Genes Dev. 9, 730-741.
20. Prokop A., Landgraf M., Rushton E., Broadie K., Bate M. (1996) Presynaptic development at the Drosophila neuromuscular junction: assembly and localization of presynaptic active zones. Neuron 17, 617-626.
21. Kolodziejczyk S.M., Wang L., Balazsi K., DeRepentigny Y., Kothary R., Megeney L.A. (1999) MEF2 is upregulated during cardiac hypertrophy and is required for normal post-natal growth of the myocardium. Curr. Biol. 9, 1203-1206.
22. Passier R., Zeng H., Frey N., et al. (2000) CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. J. Clin. Invest. 105, 1395-1406.
23. Zhang C.L., McKinsey T.A., Chang S., Antos C.L., Hill J.A., Olson E.N. (2002) Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 110, 479-488.
24. Youn H.D., Sun L., Prywes R., Liu J.O. (1999) Apoptosis of T cells mediated by Ca2+-induced release of the transcription factor MEF2. Science 286, 790-793.
25. Youn H.D., Chatila T.A., Liu J.O. (2000) Integration of calcineurin and MEF2 signals by the coactivator p300 during T-cell apoptosis. Embo J. 19, 4323-4331.
26. Leifer D., Golden J., Kowall N.W. (1994) Myocyte-specific enhancer binding factor 2C expression in human brain development. Neuroscience 63, 1067-1079.
27. Lyons G.E., Micales B.K., Schwarz J., Martin J.F., Olson E.N. (1995) Expression of mef2 genes in the mouse central nervous system suggests a role in neuronal maturation. J. Neurosci. 15, 5727-5738.
28. Ikeshima H., Imai S., Shimoda K., Hata J., Takano T. (1995) Expression of a MADS box gene, MEF2D, in neurons of the mouse central nervous system: implication of its binary function in myogenic and neurogenic cell lineages. Neurosci. Lett. 200, 117-120.
29. Mao Z., Wiedmann M. (1999) Calcineurin enhances MEF2 DNA binding activity in calcium-dependent survival of cerebellar granule neurons. J. Biol. Chem. 274, 31102-31107.
30. Lin X., Shah S., Bulleit R.F. (1996) The expression of MEF2 genes is implicated in CNS neuronal differentiation. Brain Res. Mol. Brain Res. 42, 307-316.
31. Mao Z., Bonni A., Xia F., Nadal-Vicens M., Greenberg M.E. (1999) Neuronal activity-dependent cell survival mediated by transcription factor MEF2. Science 286, 785-790.
32. Li M., Linseman D.A., Allen M.P., et al. (2001) Myocyte enhancer factor 2A and 2D undergo phosphorylation and caspase-mediated degradation during apoptosis of rat cerebellar granule neurons. J. Neurosci. 21, 6544-6552.
33. Gaudilliere B., Shi Y., Bonni A. (2002) RNA interference reveals a requirement for myocyte enhancer factor 2A in activity-dependent neuronal survival. J. Biol. Chem. 277, 46442-46446.
34. Okamoto S., Li Z., Ju C., Scholzke M.N., Mathews E., et al. (2002) Dominant-interfering forms of MEF2 generated by caspase cleavage contribute to NMDA-induced neuronal apoptosis. Proc. Natl. Acad. Sci. USA 99, 3974-3979.
35. Okamoto S., Krainc D., Sherman K., Lipton S.A. (2000) Antiapoptotic role of the p38 mitogen-activated protein kinase-myocyte enhancer factor 2 transcription factor pathway during neuronal differentiation. Proc. Natl. Acad. Sci. USA 97, 7561-7566.
36. Skerjanc I.S., Wilton S. (2000) Myocyte enhancer factor 2C upregulates MASH-1 expression and induces neurogenesis in P19 cells. FEBS Lett. 472, 53-56.
37. Krainc D., Bai G., Okamoto S., et al. (1998) Synergistic activation of the N-methyl-D-aspartate receptor subunit 1 promoter by myocyte enhancer factor 2C and Sp1. J. Biol. Chem. 273, 26218-26224.
38. Allen M.P., Xu M., Linseman D.A., et al. (2002) Adhesion-related kinase repression of gonadotropin-releasing hormone gene expression requires Rac activation of the extracellular signal-regulated kinase pathway. J. Biol. Chem. 277, 38133-38140.
39. Molkentin J.D., Li L., Olson E.N. (1996) Phosphorylation of the MADS-Box transcription factor MEF2C enhances its DNA binding activity. J. Biol. Chem. 271, 17199-17204.
40. Yang S.H., Galanis A., Sharrocks A.D. (1999) Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors. Mol. Cell. Biol. 19, 4028-4038.
41. Zhao M., New L., Kravchenko V.V., et al. (1999) Regulation of the MEF2 family of transcription factors by p38. Mol. Cell. Biol. 19, 21-30.
42. Wu Z., Woodring P.J., Bhakta K.S., et al. (2000) p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps. Mol. Cell. Biol. 20, 3951-3964.
43. Ornatsky O.I., Cox D.M., Tangirala P, et al. (1999) Post-translational control of the MEF2A transcriptional regulatory protein. Nucleic Acids Res. 27, 2646-2654.
44. Han J., Jiang Y., Li Z., Kravchenko V.V., Ulevitch R.J. (1997) Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature 386, 296-299.
45. Wu H., Naya F.J., McKinsey T.A., et al. (2000) MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type. Embo J. 19, 1963-1973.
46. Kato Y., Kravchenko V.V., Tapping R.I., Han J., Ulevitch R.J., Lee J.D. (1997) BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. Embo J. 16, 7054-7066.
47. Yang C.C., Ornatsky O.I., McDermott J.C., Cruz T.F., Prody C.A. (1998) Interaction of myocyte enhancer factor 2 (MEF2) with a mitogen-activated protein kinase, ERK5/BMK1. Nucleic Acids Res. 26, 4771-4777.
48. Kato Y., Zhao M., Morikawa A., et al. (2000) Big mitogen-activated kinase regulates multiple members of the MEF2 protein family. J. Biol. Chem. 275, 18534-18540.
49. Marinissen M.J., Chiariello M., Pallante M., Gutkind J.S. (1999) A network of mitogen-activated protein kinases links G protein-coupled receptors to the c-jun promoter: a role for c-Jun NH2-terminal kinase, p38s, and extracellular signal-regulated kinase 5. Mol. Cell. Biol. 19, 4289-4301.
50. Kasler H.G., Victoria J., Duramad O., Winoto A. (2000) ERK5 is a novel type of mitogen-activated protein kinase containing a transcriptional activation domain. Mol. Cell. Biol. 20, 8382-8389.
51. Liu L., Cavanaugh J.E., Wang Y., Sakagami H., Mao Z., Xia Z. (2003) ERK5 activation of MEF2-mediated gene expression plays a critical role in BDNF-promoted survival of developing but not mature cortical neurons. Proc. Natl. Acad. Sci. USA 100, 8532-8537.
52. Shalizi A., Lehtinen M., Gaudilliere B., et al. (2003) Characterization of a neurotrophin signaling mechanism that mediates neuron survival in a temporally specific pattern. J. Neurosci. 23, 7326-7336.
53. Linseman D.A., Cornejo B.J., Le S.S., et al. (2003) A myocyte enhancer factor 2D (MEF2D) kinase activated during neuronal apoptosis is a novel target inhibited by lithium. J. Neurochem. 85, 1488-1499.
54. Gong X., X. T, Wiedmann M, Wang X, et al. (2003) Cdk-5 mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis. Neuron 38, 33-46.
55. Grant P., Sharma P., Pant H.C. (2001) Cyclin-dependent protein kinase 5 (Cdk5) and the regulation of neurofilament metabolism. Eur. J. Biochem. 268, 1534-1546.
56. Bajaj N.P. (2000) Cyclin-dependent kinase-5 (CDK5) and amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 1, 319-327.
57. Maccioni R.B., Otth C., Concha I.I., Munoz J.P. (2001) The protein kinase Cdk5. Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology. Eur. J. Biochem. 268, 1518-1527.
58. Takahashi M., Iseki E., Kosaka K. (2000) Cyclin-dependent kinase 5 (Cdk5) associated with Lewy bodies in diffuse Lewy body disease. Brain Res. 862, 253-256.
59. Lu J., McKinsey T.A., Zhang C.L., Olson E.N. (2000) Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol. Cell 6, 233-244.
60. McKinsey T.A., Zhang C.L., Lu J., Olson E.N. (2000) Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 408, 106-111.
61. Kao H.Y., Verdel A., Tsai C.C., Simon C., Juguilon H., Khochbin S. (2001) Mechanism for nucleocytoplasmic shuttling of histone deacetylase 7. J. Biol. Chem. 276, 47496-47507.
62. Zhang C.L., McKinsey I.A., Olson E.N. (2001) The transcriptional corepressor MITR is a signal-responsive inhibitor of myogenesis. Proc. Natl. Acad. Sci. USA 98, 7354-7359.
63. Linseman P.A., Bartley C.M., Le S.S., et al. (2003). Inactivation of the myocyte enhancer factor-2 repressor histone deacetylase-5 by endogenous Ca(2+)/calmodulin-dependent kinase II promotes depolarization-mediated cerebellar granule neuron survival. J. Biol. Chem. 278, 41472-41481.
64. Chawla S., Vanhoutte P., Arnold F.J., Huang C.L., Bading H. (2003) Neuronal activity-dependent nucleocytoplasmic shuttling of HDAC4 and HDAC5. J. Neurochem. 85, 151-159.